Alle Fotos(1)

Dokumente

Y0000762

Fluorouracil Unreinheit A

Name: Fluorouracil Unreinheit A
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

Barbitursäure, 2,4,6-Trihydroxy-pyrimidin, Malonylharnstoff

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):

C₄H₄N₂O₃

CAS-Nummer:

67-52-7

Molekulargewicht:

128.09

Beilstein:

120502

MDL-Nummer:

MFCD00006666

UNSPSC-Code:

12352200

PubChem Substanz-ID:

329831134

NACRES:

NA.24

Empfohlene Produkte

Slide 1 of 10

1 of 10

Sigma-Aldrich

185698

Barbitursäure

USP

1029512

Amlodipin-verwandte Verbindung A

USP

1029545

Amlodipin-verwandte Verbindung D

Supelco

1.00132

Barbitursäure

Sigma-Aldrich

11715

Barbitursäure Natriumsalz

Y0001067

Amlodipin für die Peakidentifizierung

Y0001068

Amlodipin Unreinheit A

USP

1279019

Fluorouracil-verwandte Verbindung A

USP

1279021

Fluoruracil-verwandte Verbindung B

Supelco

I0627

Isobarbitursäure

Qualität

pharmaceutical primary standard

API-Familie

fluorouracil

Hersteller/Markenname

EDQM

mp (Schmelzpunkt)

248-252 °C (dec.) (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

O=C1CC(=O)NC(=O)N1

InChI

1S/C4H4N2O3/c7-2-1-3(8)6-4(9)5-2/h1H2,(H2,5,6,7,8,9)

InChIKey

HNYOPLTXPVRDBG-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Fluorouracil impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 1

Flammpunkt (°F)

302.0 °F - closed cup

Flammpunkt (°C)

150.00 °C - closed cup

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate.

Ayman K Hamouda et al.

Molecular pharmacology, 85(5), 735-746 (2014-02-25)

At concentrations that produce anesthesia, many barbituric acid derivatives act as positive allosteric modulators of inhibitory GABAA receptors (GABAARs) and inhibitors of excitatory nicotinic acetylcholine receptors (nAChRs). Recent research on [(3)H]R-mTFD-MPAB ([(3)H]R-5-allyl-1-methyl-5-(m-trifluoromethyldiazirinylphenyl)barbituric acid), a photoreactive barbiturate that is a potent

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Roosmarijn E Vandenbroucke et al.

Nature reviews. Drug discovery, 13(12), 904-927 (2014-11-08)

Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of 24 members in mammals. Evidence of the pathological roles of MMPs in various diseases, combined with their druggability, has made them attractive therapeutic targets. Initial drug discovery efforts focused

Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.

Rémi Legay et al.

Journal of pharmaceutical and biomedical analysis, 98, 446-462 (2014-07-20)

The purpose of the study was to investigate the degradation pathway of 5-fluorouracil (FU) in the situation of commercial formulations for clinical use, namely FU dissolved in sodium hydroxide (NaOH) solutions or Tris buffer at pH 8.5-9. Combination of data

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.